Stock Events

Stock Events

Avalo Therapeutics (AVTX) Q3 2024 Earnings

12AugConfirmed

Q2 2023

Q3 2023

Q2 2024

Q3 2024

-141

-94.04

-47.07

-0.11

Details

Expected EPS

-6.7

Actual EPS

-14.07

Surprise EPS

-7.37

Surprise Percent

+110%

Description

Avalo Therapeutics (AVTX) has reported earnings of -14.07 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.